XML 27 R10.htm IDEA: XBRL DOCUMENT
v3.3.1.900

Selected Balance Sheet Information | 12 Months Ended
--- | ---
Dec. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
Supplemental Balance Sheet Disclosures [Text Block] | ## 3. Selected Balance Sheet Information #### Prepaid expenses and other current assets (in thousands):
|  | December 31,
|  | 2015 |  | 2014
Intrexon prepaid research and development expenses – See Note 7 |  | $ | 643 |  |  | $ | 1,067 |
Prepaid clinical research organization expenses |  |  | 8,329 |  |  |  | — |
Prepaid insurances |  |  | 339 |  |  |  | 228 |
Other prepaid expenses |  |  | 208 |  |  |  | 253 |
Total |  | $ | 9,519 |  |  | $ | 1,548 |
The Intrexon prepaid research and development expenses are classified as a current asset. The Company may terminate the arrangement at any time and receive a cash refund of the remaining balance minus any amounts owed to Intrexon. The Company anticipates that the majority of the prepaid will be applied to research and development expenses during 2016. Prepaid clinical research organization expense are classified as a current asset. The Company makes payments to the clinical research organizations based on agreed upon terms that includes payments in advance of study services. The Company anticipates that the majority of the prepaid clinical research organization expenses will be applied to research and development expenses during 2016. #### Property and equipment (in thousands):
|  | December 31,
|  | 2015 |  | 2014
Computer and office equipment |  | $ | 346 |  |  | $ | 93 |
Software |  |  | 11 |  |  |  | 11 |
Leasehold improvements |  |  | 242 |  |  |  | — |
|  |  | 599 |  |  |  | 104 |
Less accumulated depreciation and amortization |  |  | (105 | ) |  |  | (39 | )
Total |  | $ | 494 |  |  | $ | 65 |
#### Accrued expenses (in thousands):
|  | December 31,
|  | 2015 |  | 2014
Accrued manufacturing costs |  | $ | — |  |  | $ | 247 |
Accrued vendor payments |  |  | 133 |  |  |  | 176 |
Accrued milestones payments |  |  | — |  |  |  | 350 |
Accrued clinical consulting services |  |  | 164 |  |  |  | 525 |
Total |  | $ | 297 |  |  | $ | 1,298 |

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References No definition available. + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration